Pessary Market: Rising Pelvic Floor Disorders Strengthen the Case for Non-Surgical Care
The pessary market is gaining attention as healthcare providers look for practical options to manage pelvic health conditions. Polaris Market Research reports that the global pessary market was valued at USD 412.2 million in 2024 and is expected to grow at a CAGR of 6.25% from 2025 to 2034, reaching USD 736.5 million by 2034. The report identifies the rising incidence of pelvic organ prolapse and a growing preference for non-surgical treatment as key growth drivers, with North America the largest market in 2024.
Pelvic Floor Disorders Drive Demand
The increasing prevalence of pelvic floor disorders is identified as the key driving factor. Vaginal pessaries are viewed as simple, affordable, and safe, which supports higher patient satisfaction than alternative treatment options. As a result, they are often prioritized as the primary treatment for pelvic organ prolapse and stress urinary incontinence. While the condition can affect women of various ages, it is more commonly observed in the aging population. According to a 2019 report from the US FDA cited in the research, the incidence of prolapse is expected to increase by 46% to reach 4.9 million cases by 2050.
The availability of products addressing pelvic support has become more widespread as awareness of these conditions grows.
Clinical Evidence and Patient Satisfaction
Stress urinary incontinence, associated with weakened pelvic muscles, is another driving factor and reinforces demand for effective pelvic support devices. Patients with poor nutritional status are more likely to experience this type of incontinence, which further emphasizes the need for advanced support solutions. The report cites a November 2021 article in the International Urogynecology Journal, which states that approximately 40% of women experience pelvic organ prolapse. The same article reports high patient satisfaction at 75.3% and efficacy at 90.7% for pessary treatment, along with positive effects on vaginal and sexual symptoms, quality of life, and mental health. Evolving lifestyles and the rapid development of noninvasive options add to the momentum, as non-surgical treatment remains a primary choice for many patients.
The pandemic had a mixed effect. Pessaries became a temporary solution because elective surgeries were delayed, although overall demand fell in the initial wave due to fewer clinic and hospital visits. Patient discomfort and concerns about side effects also influence adoption.
Browse In-depth Market Research Report:
https://www.polarismarketresearch.com/industry-analysis/pessary-market
Innovation and Market Developments
Continuous product launches, geographic expansion, strong research and development, and government initiatives are expected to support growth. In February 2021, Cosm Medical obtained Health Canada Investigational Testing Authorization approval for a clinical study of its Gynethotics customized gynecological prosthetics, which use ultrasound-based pelvic floor measurement to design devices around each patient's anatomy and lifestyle. The report also points to growing acceptance of at-home women's health technologies, including the FDA approval of the Teal Wand in May 2025 and a September 2024 collaboration to advance the launch of the ProVate device, a minimally invasive, at-home option for prolapse.
The report's market dynamics list awareness and education programs as an opportunity, while the risk of complications and a preference for surgical interventions appear among the restraints. Porter's analysis rates rivalry among existing firms as high and the threat of new entrants as low, which indicates a competitive but difficult-to-enter field.
Lockdowns and movement restrictions during the pandemic also directly affected production. In March 2025, the FDA authorized Visby Medical's first at-home STI test for chlamydia, gonorrhea, and trichomoniasis, another sign of growing acceptance of at-home women's health technologies.
Key Players in the Pessary Market
- Bioteque America
- Bliss GVS Pharma
- CooperSurgical Inc.
- Arabin GmbH & Co. KG
- Integra LifeSciences
- MedGyn
- Panpac Medical Corporation
- Personal Medical Corporation
- Wallach Surgical Devices
Conclusion
The pessary market is supported by clear clinical and demographic factors. With a valuation of USD 412.2 million in 2024 and a 6.25% CAGR through 2034, the market reflects demand linked to pelvic floor disorders, an aging population, and a continued preference for non-surgical treatment. Manufacturers, clinicians, and healthcare investors can use these insights to align product development with the needs of patients affected by prolapse and stress urinary incontinence.
More Trending Latest Reports By Polaris Market Research:
Battery Energy Storage System Market Size
Fire Resistant Fabrics Market Share
Silicone Elastomers Market Growth
Herbal Supplements Market Forecast
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Jogos
- Gardening
- Health
- Início
- Literature
- Music
- Networking
- Outro
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness